港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

晶泰控股-P

4.280

-0.220-4.89%

成交量：7,231.88萬

成交額：3.12億

市值：172.06億

市盈率：-5.03

高：4.510

開：4.510

低：4.210

收：4.500

資料載入中...

總覽公司新聞公告

港股異動 | AI醫療概念股早盤走強 AI賦能醫藥醫療不斷取得新進展多家醫療公司表態接入DeepSeek

晶泰(02228.HK)完成對或然生物戰略投資推進首創新藥研發

阿斯达克财经

異動解讀 | AI製藥前景看好,晶泰控股-P盤中大漲6.26%

晶泰控股-P盤中異動早盤急速上漲6.77%

晶泰控股－Ｐ(02228)出現大手賣出340萬股，成交價$6.28，涉資2.135千萬

阿斯达克财经

晶泰科技戰略投資或然生物，強強聯合加速首創新藥開發

醫藥生物行業跟蹤週報：AI醫療仍被顯著低估，關注華大智造、晶泰控股-P等

異動解讀 | 晶泰控股-P(02228)盤中大漲5.32% 與韓國藥企簽署合作增加業務訂單

晶泰控股-P盤中異動快速上漲5.14%

晶泰控股-P02月05日主力資金流入327萬元連續3日加倉

晶泰控股－Ｐ(02228)出現大手賣出96.9萬股，成交價$5.64，涉資546.516萬

阿斯达克财经

港股概念追蹤|高盛將目光投向“AI+醫療” 行業回暖拐點降至（附概念股）

晶泰控股-P現漲逾7% 與韓國藥企JW簽署千萬級人民幣戰略合作協議

異動解讀 | 晶泰控股-P盤中大漲8.55% 攜手韓國藥企開拓海外市場

晶泰控股－Ｐ(02228)股價上升5.019%，現價港幣$5.65

阿斯达克财经

晶泰控股-P現漲逾9% 公司與韓國製藥企業JW達成合作

【港股通】晶泰控股(02228)漲10.64% 與韓製藥企業JW合作以AI+機器人打造藥物合成實驗室

異動解讀 | 夥韓國JW Pharmaceutical研發新藥晶泰控股盤中大漲5.02%

晶泰控股-P(02228)上漲5.02%，報5.23元/股

晶泰控股-P盤中異動早盤股價大漲5.02%

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02228/news?page=10"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02228","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02228\",,,,,undefined,":{"symbol":"02228","market":"HK","secType":"STK","nameCN":"晶泰控股-P","latestPrice":4.28,"timestamp":1747296514029,"preClose":4.5,"halted":0,"volume":72318770,"delay":0,"floatShares":4020000000,"shares":4020000000,"eps":-0.8515273619950825,"marketStatus":"未開盤","change":-0.22,"latestTime":"05-15 16:08:34","open":4.51,"high":4.51,"low":4.21,"amount":312372052,"amplitude":0.066667,"askPrice":4.28,"askSize":18000,"bidPrice":4.27,"bidSize":107000,"shortable":3,"etf":0,"ttmEps":-0.8558194590797331,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1747359000000},"marketStatusCode":0,"adr":0,"listingDate":1718208000000,"exchange":"SEHK","adjPreClose":4.5,"openAndCloseTimeList":[[1747272600000,1747281600000],[1747285200000,1747296000000]],"volumeRatio":1.257145,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02228\",,,,,undefined,":{"symbol":"02228","floatShares":4020000000,"roa":"-10.69%","roe":"--","lyrEps":-0.851527,"volumeRatio":1.257145,"shares":4020000000,"dividePrice":0,"high":4.51,"amplitude":0.066667,"preClose":4.5,"low":4.21,"week52Low":3.05,"pbRate":"4.01","psRate":"59.61","week52High":16.2,"institutionHeld":0,"latestPrice":4.28,"committee":0.712,"eps":-0.8515273619950825,"divideRate":0,"volume":72318770,"delay":0,"ttmEps":-0.8558194590797331,"open":4.51,"prevYearClose":5.98,"prevWeekClose":4.63,"prevMonthClose":5.16,"prevQuarterClose":5.89,"fiveDayClose":4.7,"twentyDayClose":4.65,"sixtyDayClose":6.05},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02228\",pageSize:20,pageCount:10,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2510006497","title":"港股異動 | AI醫療概念股早盤走強 AI賦能醫藥醫療不斷取得新進展 多家醫療公司表態接入DeepSeek","url":"https://stock-news.laohu8.com/highlight/detail?id=2510006497","media":"智通财经","labels":["corporation","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510006497?lang=zh_tw&edition=fundamental","pubTime":"2025-02-10 11:31","pubTimestamp":1739158274,"startTime":"0","endTime":"0","summary":"木头姐强调称，医疗保健是最被低估的AI应用。国金证券认为，随着人工智能技术的发展与进步，AI在赋能医药医疗、推动行业升级方面不断取得新进展，人工智能在医药健康领域的应用有望进入加速发展阶段。此外，多家医疗公司近期相继表态接入deepseek。企业有望借助AI进一步提高产品竞争力和客户粘性，巩固行业地位和竞争优势。此外，用好Deepseek等AI工具有助于企业降本增效、改善盈利水平。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1247612.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02252","09955","159891","02228","159938","02158","02192","09939"],"gpt_icon":0},{"id":"2510003387","title":"晶泰(02228.HK)完成對或然生物戰略投資 推進首創新藥研發","url":"https://stock-news.laohu8.com/highlight/detail?id=2510003387","media":"阿斯达克财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510003387?lang=zh_tw&edition=fundamental","pubTime":"2025-02-10 10:33","pubTimestamp":1739154780,"startTime":"0","endTime":"0","summary":"晶泰控股-P公布，完成对或然生物的战略投资，并建立深度研发合作。双方正基于或然生物在全球未满足的临床需求领域所发现的First-in-Class靶点，共同推进创新药物研发。或然生物联合创始人、首席运营官杨彬表示，期待在AI新药研发平台赋能下加快速度，开发出更多高特异性、低毒副作用和具有巨大临床价值的小分子抑制剂，将优质高效的药物尽早带给全球患者。晶泰现报6.47元，升9.48%，成交1.32亿股，涉资8.53亿元。沽空资料截至 2025-02-07 16:25。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20240611135659493_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20240611135659493_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1415905/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02228","BK1574","BK1161","BK1141","06978","159992"],"gpt_icon":0},{"id":"1112152431","title":"異動解讀 | AI製藥前景看好,晶泰控股-P盤中大漲6.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=1112152431","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112152431?lang=zh_tw&edition=fundamental","pubTime":"2025-02-10 09:30","pubTimestamp":1739151023,"startTime":"0","endTime":"0","summary":"2月10日,晶泰控股-P(02228)股价盘中大涨6.26%,引起市场关注。\n\n对于这次晶泰控股-P股价上涨,投资者普遍认为,与公司在人工智能(AI)制药领域的布局前景较好有关。近日,东吴证券发布医药生物行业研报指出,随着生成式AI与传统AI结合,AI医疗技术将为疾病诊断、风险预测和个性化治疗方案提供新动能,给制药行业带来创新机遇。报告建议重点关注晶泰控股-P等一批AI制药龙头企业。\n\n业内人士分析认为,晶泰控股-P致力于利用AI技术促进新药研发,在AI辅助药物发现、临床前评估等领域已取得一定成绩。未来,随着AI医疗不断发展,公司有望进一步受益。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | AI制药前景看好,晶泰控股-P盘中大涨6.26%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02228"],"gpt_icon":0},{"id":"2510072736","title":"晶泰控股-P盤中異動 早盤急速上漲6.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510072736","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510072736?lang=zh_tw&edition=fundamental","pubTime":"2025-02-10 09:30","pubTimestamp":1739151006,"startTime":"0","endTime":"0","summary":"2025年02月10日早盘09时30分，晶泰控股-P股票出现异动，股价快速上涨6.77%。晶泰控股-P股票所在的生物技术行业中，整体跌幅为0.29%。其相关个股中，晶泰控股-P、科济药业-B、来凯医药-B涨幅较大，振幅较大的相关个股有和铂医药-B、晶泰控股-P、科济药业-B，振幅分别为1.93%、1.52%、1.07%。晶泰控股-P公司简介：晶泰控股有限公司是一家主要从事为制药及材料科学等产业提供药物及材料科学研发解决方案及服务的控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210093006987fc0f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210093006987fc0f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02228","BK1141"],"gpt_icon":0},{"id":"2510072103","title":"晶泰控股－Ｐ(02228)出現大手賣出340萬股，成交價$6.28，涉資2.135千萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2510072103","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510072103?lang=zh_tw&edition=fundamental","pubTime":"2025-02-10 09:20","pubTimestamp":1739150400,"startTime":"0","endTime":"0","summary":"[大手成交]晶泰控股－Ｐ(02228)在上午09:20出现大手卖出，成交量为340万，成交价为港币$6.28，涉资2.135千万。至目前为止，股价升6.261%，今日最高价为$6.28，而最低价为$6.28，总成交量为340万股，总成交金额港币$2.135千万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126132514810_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126132514810_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT25021045/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1141","02228"],"gpt_icon":0},{"id":"2510507284","title":"晶泰科技戰略投資或然生物，強強聯合加速首創新藥開發","url":"https://stock-news.laohu8.com/highlight/detail?id=2510507284","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510507284?lang=zh_tw&edition=fundamental","pubTime":"2025-02-10 09:02","pubTimestamp":1739149320,"startTime":"0","endTime":"0","summary":"此次获得晶泰科技的战略投资和技术合作，将进一步加速或然生物的管线开发。晶泰科技的一站式药物研发平台已经成功助力国内外多家大型药企与创新生物科技公司快速取得管线突破，此次强强联合，将为或然生物开发高价值的药物管线注入强劲的创新驱动力。或然生物旨在蛋白翻译调控领域挖掘潜在靶标，以治疗最具挑战性的疾病，而晶泰科技在挑战全新靶点上具备独到的AI技术优势，双方的密切合作将会大大加速First-in-Class药物靶点和管线研发进程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4615194_ZH15194_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK1141","02228"],"gpt_icon":0},{"id":"2510304192","title":"醫藥生物行業跟蹤週報：AI醫療仍被顯著低估，關注華大智造、晶泰控股-P等","url":"https://stock-news.laohu8.com/highlight/detail?id=2510304192","media":"东吴证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510304192?lang=zh_tw&edition=fundamental","pubTime":"2025-02-09 22:07","pubTimestamp":1739110039,"startTime":"0","endTime":"0","summary":"关注AI医疗投资机会。具体思路：1）从成长性角度选股，主要集中在AI医疗、创新药领域，建议关注润达医疗、晶泰控股-P、百利天恒、百济神州、益方生物、迪哲医药、海思科等；科伦博泰、信达生物、三生制药、歌礼制药等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250209220724987f68c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250209220724987f68c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02228","688114","BK1141"],"gpt_icon":0},{"id":"1121971947","title":"異動解讀 | 晶泰控股-P(02228)盤中大漲5.32% 與韓國藥企簽署合作增加業務訂單","url":"https://stock-news.laohu8.com/highlight/detail?id=1121971947","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121971947?lang=zh_tw&edition=fundamental","pubTime":"2025-02-06 09:48","pubTimestamp":1738806531,"startTime":"0","endTime":"0","summary":"$晶泰控股-P$今日盘中涨幅一度扩大至5.32%,引起了市场的广泛关注。这无疑为晶泰科技增加了宝贵的海外药企客户订单,标志着其实验室自动化解决方案在海外市场进一步拓展,有助于提高公司的营收和利润。另一方面,晶泰科技上月才完成了一次大规模的配股融资,成功募集超过11.3亿港元资金,金额更是超过其首次公开募股时的募资规模。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02228"],"gpt_icon":0},{"id":"2509260383","title":"晶泰控股-P盤中異動 快速上漲5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509260383","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509260383?lang=zh_tw&edition=fundamental","pubTime":"2025-02-06 09:31","pubTimestamp":1738805512,"startTime":"0","endTime":"0","summary":"2025年02月06日早盘09时31分，晶泰控股-P股票出现波动，股价急速拉升5.14%。截至发稿，该股报5.930港元/股，成交量966.7万股，换手率0.26%，振幅4.61%。晶泰控股-P股票所在的生物技术行业中，整体涨幅为0.23%。其相关个股中，晶泰控股-P、再鼎医药、奥星生命科技涨幅较大，振幅较大的相关个股有晶泰控股-P、乐普生物-B、亚盛医药-B，振幅分别为4.26%、3.75%、2.34%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206093152abc408b3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206093152abc408b3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","02228"],"gpt_icon":0},{"id":"2509479497","title":"晶泰控股-P02月05日主力資金流入327萬元 連續3日加倉","url":"https://stock-news.laohu8.com/highlight/detail?id=2509479497","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509479497?lang=zh_tw&edition=fundamental","pubTime":"2025-02-05 16:17","pubTimestamp":1738743425,"startTime":"0","endTime":"0","summary":"02月05日, 晶泰控股-P股价涨4.83%，报收5.64元，成交金额9.96亿元，换手率4.78%，振幅15.43%，量比2.83。晶泰控股-P今日主力资金净流入327万元，连续3日净流入，上一交易日主力净流入695万元。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为62.50%，平均涨幅为7.10%。该股近5个交易日上涨14.23%，主力资金累计净流出1670万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入3101万元，其中净流入天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205161747abc314be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205161747abc314be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","02228"],"gpt_icon":0},{"id":"2509408053","title":"晶泰控股－Ｐ(02228)出現大手賣出96.9萬股，成交價$5.64，涉資546.516萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2509408053","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509408053?lang=zh_tw&edition=fundamental","pubTime":"2025-02-05 16:08","pubTimestamp":1738742880,"startTime":"0","endTime":"0","summary":"[大手成交]晶泰控股－Ｐ(02228)在下午04:08出现大手卖出，成交量为96.9万，成交价为港币$5.64，涉资546.516万。至目前为止，股价升4.833%，今日最高价为$5.98，而最低价为$5.15，总成交量为1.759亿股，总成交金额港币$9.957亿。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180815142908927_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180815142908927_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAV2502056534/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02228","BK1141"],"gpt_icon":0},{"id":"2509218674","title":"港股概念追蹤|高盛將目光投向“AI+醫療”  行業回暖拐點降至（附概念股）","url":"https://stock-news.laohu8.com/highlight/detail?id=2509218674","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509218674?lang=zh_tw&edition=fundamental","pubTime":"2025-02-05 14:05","pubTimestamp":1738735540,"startTime":"0","endTime":"0","summary":"中信建投表示，近期多项创新器械陆续获批，商保有望为创新产品放量打开新空间，国内AI医疗发展迅速、海外和国内脑机接口技术进展有望持续催化。信达证券发布研报称，2024年医药生物行业在高基数、医疗反腐、DRGS改革、集采降价等因素影响下，行业整体增长承压。展望2025年，商保及AI医疗或助行业转暖，行业拐点将至。AI医疗智能大脑YiduCore赋能全场景解决方案落地。晶泰科技宣布与韩国药企JW Pharmaceutical签署千万级人民币的战略合作协议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1245880.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","LU2237443465.HKD","LU2237443382.USD","BK1518","LU0106831901.USD","02506","LU2237443895.HKD","LU2237438978.USD","IE00B19Z3581.USD","YANG","BK4585","BK1141","BK4504","159891","LU1668664300.SGD","IE00BFXG1179.USD","02158","BK4552","BK4516","BK1189","IE0004086264.USD","LU1791807156.HKD","LU2237443622.USD","LU2237443978.SGD","LU2237443549.SGD","02228","HSCEI","BK4533","IE0002270589.USD","IE0004091025.USD","BK4550","IE00BSNM7G36.USD","HSTECH","IE0034235188.USD","IE00B19Z3B42.SGD","BK4127"],"gpt_icon":1},{"id":"2509700441","title":"晶泰控股-P現漲逾7% 與韓國藥企JW簽署千萬級人民幣戰略合作協議","url":"https://stock-news.laohu8.com/highlight/detail?id=2509700441","media":"新浪港股","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509700441?lang=zh_tw&edition=fundamental","pubTime":"2025-02-05 11:05","pubTimestamp":1738724700,"startTime":"0","endTime":"0","summary":"　　晶泰控股-P早盘再走高，该股昨日收涨逾8%。截至发稿，股价上涨6.69%，现报5.74港元，成交额3.97亿港元。　　消息面上，晶泰科技昨日宣布与亚洲领先的韩国药企JW Pharmaceutical签署千万级人民币的战略合作协议。晶泰科技将为 JW 提供一套药物发现自动化工作站和基于人工智能的化学反应优化平台，以全面赋能JW的药物研发效率、重复性与成功率。此次与JW的合作，标志着晶泰科技自动化实验室解决方案首次获得海外药企客户的采购，具有重要的里程碑意义。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-02-05/doc-ineikxsm5402701.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02228","BK1141"],"gpt_icon":0},{"id":"1159855593","title":"異動解讀 | 晶泰控股-P盤中大漲8.55% 攜手韓國藥企開拓海外市場","url":"https://stock-news.laohu8.com/highlight/detail?id=1159855593","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159855593?lang=zh_tw&edition=fundamental","pubTime":"2025-02-05 10:54","pubTimestamp":1738724096,"startTime":"0","endTime":"0","summary":"晶泰控股-P(02228)今日盘中大涨8.55%,引起了市场的广泛关注。\n\n消息面上,晶泰科技昨日宣布与亚洲领先的韩国药企JW Pharmaceutical签署千万级人民币的战略合作协议。根据协议,晶泰科技将为JW部署一系列高通量自动化合成工站、AI反应条件优化系统及智能分析平台,以满足JW在自动化药物候选分子筛选、合成与工艺优化方向的复杂研发需求。\n\n这一合作标志着晶泰科技自动化实验室解决方案首次获得海外药企客户的采购,具有重要的里程碑意义。市场认为,此举有助于晶泰科技开拓海外市场,增强了公司业务增长前景的信心,推动股价上涨。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02228"],"gpt_icon":0},{"id":"2509096446","title":"晶泰控股－Ｐ(02228)股價上升5.019%，現價港幣$5.65","url":"https://stock-news.laohu8.com/highlight/detail?id=2509096446","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509096446?lang=zh_tw&edition=fundamental","pubTime":"2025-02-05 10:25","pubTimestamp":1738722300,"startTime":"0","endTime":"0","summary":"[上升股]晶泰控股－Ｐ(02228) 股价在上午10:25比前收市价上升5.019%，现股价为港币$5.65。至目前为止，今日最高价为$5.65，而最低价为$5.15。总成交量为3.454千万股，总成交金额为港币$1.849亿。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2502051966/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1141","02228"],"gpt_icon":0},{"id":"2508109101","title":"晶泰控股-P現漲逾9% 公司與韓國製藥企業JW達成合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2508109101","media":"新浪港股","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508109101?lang=zh_tw&edition=fundamental","pubTime":"2025-02-04 11:01","pubTimestamp":1738638060,"startTime":"0","endTime":"0","summary":"　　晶泰控股-P早盘一度涨超12%，截至发稿，股价上涨8.64%，报5.41港元，成交额1.13亿港元。　　消息面上，晶泰科技今日宣布，与亚洲领先的韩国药企JW Pharmaceutical签署千万级人民币的战略合作协议。晶泰科技将为JW提供一套药物发现自动化工作站和基于人工智能的化学反应优化平台，以全面赋能JW的药物研发效率、重复性与成功率。此次与JW的合作，标志着晶泰科技自动化实验室解决方案首次获得海外药企客户的采购，具有重要的里程碑意义。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-02-04/doc-ineihuth3950976.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","02228","01477","BK1141","BK1191"],"gpt_icon":0},{"id":"2508109979","title":"【港股通】晶泰控股(02228)漲10.64% 與韓製藥企業JW合作 以AI+機器人打造藥物合成實驗室","url":"https://stock-news.laohu8.com/highlight/detail?id=2508109979","media":"金吾财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508109979?lang=zh_tw&edition=fundamental","pubTime":"2025-02-04 10:39","pubTimestamp":1738636769,"startTime":"0","endTime":"0","summary":"金吾财讯 | 晶泰控股(02228)股价发力，截至发稿，涨10.64%，报5.5港元，成交额9121万港元。消息面上，晶泰科技宣布，与亚洲领先的韩国药企JW Pharmaceutical签署千万级人民币的战略合作协议。晶泰科技将为JW提供一套药物发现自动化工作站和基于人工智能（AI）的化学反应优化平台，以全面赋能JW的药物研发效率、重复性与成功率。据悉，晶泰科技将为JW部署一系列高通量自动化合成工站、AI反应条件优化系统及智能分析平台，以满足JW在自动化药物候选分子筛选、合成与工艺优化方向的复杂研发需求。","market":"nz","thumbnail":"https://static.szfiu.com/news/20241108/MGQ5MWNhYjgxMjA0ZDU3OGI4Y2EzYTk1OWIyNGM1NTg2NTUyNjEzMTk5Ng==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MGQ5MWNhYjgxMjA0ZDU3OGI4Y2EzYTk1OWIyNGM1NTg2NTUyNjEzMTk5Ng==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1952435","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","BK1191","01477","BK1574","02228","YANG","HSTECH","07226","HSCEI"],"gpt_icon":0},{"id":"1101858094","title":"異動解讀 | 夥韓國JW Pharmaceutical研發新藥 晶泰控股盤中大漲5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=1101858094","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101858094?lang=zh_tw&edition=fundamental","pubTime":"2025-02-04 09:56","pubTimestamp":1738634200,"startTime":"0","endTime":"0","summary":"晶泰控股今日盘中大涨5.02%,股价表现亮眼。据了解,公司与韩国知名药企JW Pharmaceutical签署战略合作协议,共同打造一系列自动化实验室和人工智能系统,推动新一代药物发现。双方希望以AI驱动药物发现,提高研发效率。晶泰控股表示,公司自动化实验室解决方案此前已获复旦大学、中石化等标杆客户采购,但JW成为首个采购的海外药企客户。此次合作有望带动晶泰控股在生物医药领域业务进一步增长,公司前景值得市场期待。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 伙韩国JW Pharmaceutical研发新药 晶泰控股盘中大涨5.02%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02228"],"gpt_icon":0},{"id":"2508105978","title":"晶泰控股-P(02228)上漲5.02%，報5.23元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2508105978","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508105978?lang=zh_tw&edition=fundamental","pubTime":"2025-02-04 09:54","pubTimestamp":1738634086,"startTime":"0","endTime":"0","summary":"2月4日，晶泰控股-P(02228)盘中上涨5.02%，截至09:54，报5.23元/股，成交2112.67万元。晶泰控股有限公司主要以量子物理、人工智能和机器人技术为基础，为全球制药、材料科学等领域提供研发解决方案及服务。公司运用量子物理原理、先进的AI技术、高性能云计算以及可扩展和标准化的机器人自动化等技术，服务于农业技术、能源、新型化学品以及化妆品等行业。截至2024年中报，晶泰控股-P营业总收入1.03亿元、净利润-12.37亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/04095447943686.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1141","02228"],"gpt_icon":0},{"id":"2508105294","title":"晶泰控股-P盤中異動 早盤股價大漲5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508105294","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508105294?lang=zh_tw&edition=fundamental","pubTime":"2025-02-04 09:54","pubTimestamp":1738634079,"startTime":"0","endTime":"0","summary":"2025年02月04日早盘09时54分，晶泰控股-P股票出现异动，股价急速上涨5.02%。截至发稿，该股报5.230港元/股，成交量411.9万股，换手率0.11%，振幅4.42%。晶泰控股-P股票所在的生物技术行业中，整体跌幅为0.07%。其相关个股中，北海康成-B、晶泰控股-P、复宏汉霖涨幅较大，振幅较大的相关个股有北海康成-B、亚盛医药-B、复宏汉霖，振幅分别为18.98%、5.18%、5.06%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204095439a23890a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204095439a23890a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","02228"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02228\",params:#limit:5,,,undefined,":[{"date":"2025-03-28","symbol":"02228","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743125400000,"name":null,"time":"","dateTimestamp":1743091200000,"actualEps":null},{"date":"2024-08-28","symbol":"02228","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724808600000,"name":null,"time":"","dateTimestamp":1724774400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02228\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02228\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1742313600000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02228\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02228","date":"2025-05-14","current":-8.240535,"percent":0.674107,"low":-19.121462,"twenty":-11.321925,"median":-8.892407,"eighty":-6.807272,"high":-4.071689,"avg":-9.331711,"sd":2.959567,"marketCap":18089152924},"quantilePoints":[{"date":"2024-06-14","current":-8.922014,"twenty":-9.439723,"median":-9.245582,"eighty":-9.051441,"marketCap":18396572909},{"date":"2024-06-21","current":-8.857946,"twenty":-8.9092,"median":-8.775161,"eighty":-8.737522,"marketCap":18226234271},{"date":"2024-06-28","current":-8.745676,"twenty":-8.918198,"median":-8.816527,"eighty":-8.750223,"marketCap":17987760178},{"date":"2024-07-05","current":-8.747576,"twenty":-8.902934,"median":-8.771787,"eighty":-8.744343,"marketCap":17987760178},{"date":"2024-07-12","current":-9.049063,"twenty":-8.902934,"median":-8.775161,"eighty":-8.741587,"marketCap":18635047002},{"date":"2024-07-19","current":-9.247407,"twenty":-9.172529,"median":-8.857489,"eighty":-8.744343,"marketCap":19043859733},{"date":"2024-07-26","current":-9.575773,"twenty":-9.510189,"median":-8.892407,"eighty":-8.745676,"marketCap":19793349741},{"date":"2024-08-02","current":-9.235042,"twenty":-9.509847,"median":-8.912474,"eighty":-8.745676,"marketCap":19077927461},{"date":"2024-08-09","current":-9.468775,"twenty":-9.510189,"median":-8.974725,"eighty":-8.747576,"marketCap":19691146558},{"date":"2024-08-16","current":-10.464009,"twenty":-9.56947,"median":-9.142341,"eighty":-8.760904,"marketCap":21769277942},{"date":"2024-08-23","current":-10.517808,"twenty":-9.632925,"median":-9.235042,"eighty":-8.768412,"marketCap":21973684308},{"date":"2024-08-30","current":-10.371399,"twenty":-10.303269,"median":-9.325095,"eighty":-8.775161,"marketCap":28923500740},{"date":"2024-09-06","current":-18.461728,"twenty":-10.496901,"median":-9.468775,"eighty":-8.776023,"marketCap":51510404146},{"date":"2024-09-13","current":-17.236995,"twenty":-10.891661,"median":-9.521964,"eighty":-8.857032,"marketCap":47967360474},{"date":"2024-09-20","current":-16.063353,"twenty":-11.51195,"median":-9.559061,"eighty":-8.857763,"marketCap":44969400445},{"date":"2024-09-27","current":-15.483466,"twenty":-14.686278,"median":-9.575773,"eighty":-8.860072,"marketCap":43606691340},{"date":"2024-10-04","current":-13.755671,"twenty":-14.947547,"median":-9.615329,"eighty":-8.879685,"marketCap":38564667654},{"date":"2024-10-10","current":-12.348216,"twenty":-14.780027,"median":-9.846626,"eighty":-8.896618,"marketCap":34408404886},{"date":"2024-10-18","current":-11.446606,"twenty":-14.586898,"median":-10.272952,"eighty":-8.910566,"marketCap":31717054404},{"date":"2024-10-25","current":-12.086709,"twenty":-14.247622,"median":-10.371399,"eighty":-8.935918,"marketCap":33488576240},{"date":"2024-11-01","current":-11.046421,"twenty":-13.547793,"median":-10.507354,"eighty":-8.963954,"marketCap":30626887121},{"date":"2024-11-08","current":-8.233542,"twenty":-13.084166,"median":-10.464009,"eighty":-8.959678,"marketCap":22655038860},{"date":"2024-11-15","current":-6.674421,"twenty":-12.818197,"median":-10.331022,"eighty":-8.873325,"marketCap":18226234271},{"date":"2024-11-22","current":-5.092957,"twenty":-12.605094,"median":-9.956054,"eighty":-8.775506,"marketCap":13899632864},{"date":"2024-11-29","current":-4.071689,"twenty":-12.362191,"median":-9.633447,"eighty":-8.746436,"marketCap":11106079200},{"date":"2024-12-06","current":-6.234627,"twenty":-12.309524,"median":-9.607633,"eighty":-8.729287,"marketCap":16965728349},{"date":"2024-12-13","current":-4.937116,"twenty":-12.241743,"median":-9.572622,"eighty":-8.309283,"marketCap":13422684678},{"date":"2024-12-20","current":-6.992956,"twenty":-12.176011,"median":-9.548971,"eighty":-7.374004,"marketCap":18907588823},{"date":"2024-12-27","current":-7.61626,"twenty":-12.099333,"median":-9.521964,"eighty":-6.992956,"marketCap":20576907476},{"date":"2025-01-03","current":-6.613619,"twenty":-12.089234,"median":-9.489311,"eighty":-6.978437,"marketCap":17885556995},{"date":"2025-01-10","current":-5.450117,"twenty":-12.058756,"median":-9.391379,"eighty":-6.644107,"marketCap":14683190599},{"date":"2025-01-17","current":-5.875315,"twenty":-12.04248,"median":-9.241225,"eighty":-6.25569,"marketCap":15841493338},{"date":"2025-01-24","current":-6.177753,"twenty":-11.949888,"median":-9.172529,"eighty":-6.11967,"marketCap":16761321984},{"date":"2025-01-28","current":-6.498305,"twenty":-11.921589,"median":-9.112153,"eighty":-6.130311,"marketCap":17715218357},{"date":"2025-02-07","current":-7.424154,"twenty":-11.872333,"median":-8.96938,"eighty":-6.148709,"marketCap":20134027017},{"date":"2025-02-14","current":-8.323374,"twenty":-11.760531,"median":-8.922014,"eighty":-6.178085,"marketCap":22518767950},{"date":"2025-02-21","current":-10.607329,"twenty":-11.720414,"median":-8.939394,"eighty":-6.187416,"marketCap":28855365285},{"date":"2025-02-28","current":-8.380735,"twenty":-11.643652,"median":-8.964036,"eighty":-6.222464,"marketCap":22723174315},{"date":"2025-03-07","current":-8.409794,"twenty":-11.556185,"median":-8.912474,"eighty":-6.239893,"marketCap":22893512953},{"date":"2025-03-14","current":-8.131514,"twenty":-11.5122,"median":-8.860603,"eighty":-6.269085,"marketCap":22144022946},{"date":"2025-03-21","current":-7.997044,"twenty":-11.440339,"median":-8.816527,"eighty":-6.340941,"marketCap":21769277942},{"date":"2025-03-28","current":-9.307254,"twenty":-11.391935,"median":-8.776023,"eighty":-6.503525,"marketCap":25284615976},{"date":"2025-04-03","current":-13.220486,"twenty":-11.563082,"median":-8.857032,"eighty":-6.524404,"marketCap":21465794803},{"date":"2025-04-11","current":-11.616184,"twenty":-11.563082,"median":-8.876505,"eighty":-6.613619,"marketCap":18692124688},{"date":"2025-04-17","current":-8.481901,"twenty":-11.535495,"median":-8.876505,"eighty":-6.644107,"marketCap":18290143512},{"date":"2025-04-25","current":-9.200975,"twenty":-11.479403,"median":-8.897671,"eighty":-6.665344,"marketCap":19857870099},{"date":"2025-05-02","current":-9.49742,"twenty":-11.434072,"median":-8.939394,"eighty":-6.691701,"marketCap":20541238098},{"date":"2025-05-09","current":-8.545306,"twenty":-11.391935,"median":-8.912474,"eighty":-6.740034,"marketCap":18611728453},{"date":"2025-05-14","current":-8.240535,"twenty":-11.321925,"median":-8.892407,"eighty":-6.807272,"marketCap":18089152924}],"updateTime":1747303401957}}}